http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RO-105130-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c9d9ac41759928cfd250c5c6195c0d3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 |
| filingDate | 1987-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_348ab6dcf022209a55bf52e5f36625d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea20441616bc799523685f85d487cb4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c2e398b349ebf1c513685a6dc10c7cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0641a7cb522290518a871ee84424ad4 |
| publicationDate | 1995-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RO-105130-B1 |
| titleOfInvention | Vaginal preparation in the form of ova |
| abstract | The vaginal preparation according to the invention is constitutednfrom rifampicin, nystatin, anesthesia, dc magnesium lactate, vitamin A + D2CU or without yolk tincture, incorporated in a bidrophilic basenconsisting of: collagen hydrolyzed gelatin withnGM = 20,000, glycerin, soy lecithin and preservative solution, condition under the form of ova. The preparation thus obtained is used in the treatmentninfectious vaginitis, chronic cervicitis,nchronic uterine inflammation etc. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005077378-A1 |
| priorityDate | 1987-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.